小细胞肺癌中的瘤异质性和可塑性
1Departments of Pediatrics and Genetics, Stanford University, Stanford, CA, USA.
Lung Cancer (Auckland, N.Z.)
|October 16, 2025
概括
小细胞肺癌 (SCLC) 的瘤异质性和细胞可塑性是由表观遗传因素驱动的,影响治疗耐药性. 了解这些机制是开发这种侵袭性癌症的新疗法的关键.
科学领域:
- 在瘤学瘤学.
- 癌症生物学 癌症生物学
- 分子生物学分子生物学
背景情况:
- 小细胞肺癌 (SCLC) 是一种具有攻击性的恶性瘤,其特点是快速生长,转移和耐治疗.
- 瘤异质性,包括多样化的细胞状态和免疫微环境,显著影响SCLC的进化和治疗反应.
- 目前对SCLC的治疗策略有限,需要对其潜在的生物机制有更深入的了解.
研究的目的:
- 审查目前关于SCLC瘤异质性和细胞状态可塑性的知识.
- 探索表观遗传因素在推动SCLC异质性的作用.
- 讨论SCLC细胞状态和免疫微环境对治疗疗效的影响.
主要方法:
- 关于SCLC瘤异质性和细胞可塑性的现有研究的文献综述.
- 对调节SCLC细胞状态转换的表观遗传机制的分析.
- 讨论SCLC细胞状态,免疫微环境和治疗结果之间的相互作用.
主要成果:
- SCLC异质性在很大程度上是由表观遗传因素而不是遗传突变驱动的.
- 高分泌癌瘤表现出多种细胞状态,包括神经内分泌 (NE) 和非神经内分泌 (non-NE) 状态,由特定的转录因子 (例如,ASCL1,NEUROD1,POU2F3) 调节.
- 表观遗传机制控制SCLC细胞的可塑性,使不同状态之间的过渡成为可能.
结论:
- 细胞状态可塑性的表观遗传调节是SCLC异质性和治疗耐药性的关键驱动因素.
- 针对SCLC的可塑性和异质性,为提高治疗疗效提供了一个有希望的途径.
- 对SCLC细胞状态及其与免疫微环境的相互作用的进一步研究对于推进治疗选择至关重要.
相关概念视频
02:40Cancer Stem Cells and Tumor Maintenance
5.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.9K
02:07Tumor Progression
7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K
02:53Adaptive Mechanisms in Cancer Cells
6.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.9K